Pascual, Gloria
Avgustinova, Alexandra
Mejetta, Stefania
Martín, Mercè
Castellanos, Andrés
Attolini, Camille Stephan-Otto
Berenguer, Antoni
Prats, Neus
Toll, Agustí
Hueto, Juan Antonio
Bescós, Coro
Di Croce, Luciano
Benitah, Salvador Aznar
Article History
Received: 16 September 2015
Accepted: 16 November 2016
First Online: 7 December 2016
Change Date: 13 December 2016
Change Type: Correction
Change Date: 4 January 2017
Change Type: Correction
Change Details: The received date was corrected in the HTML.
Change Details: The Competing Interests statement and the Acknowledgements funding information were updated.
Competing interests
: The Institute for Research in Biomedicine in Barcelona has filed a provisional patent application that covers the application of inhibition of the fatty acid receptor CD3 by any method as an antimetastatic therapy against oral squamous cell carcinoma (European patent application number EP 2016/073208). Authors S.A.B., G.P., A.C. and M.M. are listed as inventors.